| Serial Number | 86104198 |
| Word Mark | GENEQURE |
| Filing Date | Tuesday, October 29, 2013 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, December 3, 2021 |
| Registration Number | 4741698 |
| Registration Date | Tuesday, May 26, 2015 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 30, 2014 |
| Goods and Services | Viral assays, viral reagents, viral preparations, gene therapy assays, gene therapy reagents, gene therapy preparations, nucleic acid delivery assays, nucleic acid delivery reagents, nucleic acid delivery preparations, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors, all for non-medical research purposes |
| Goods and Services | Viral medicines, gene therapy medicines, nucleic acid delivery medicines, viralvectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors and nucleic acid delivery vectors for medical purposes all for medical treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single genedisorders and cancers; pharmaceutical preparations and substances for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inheriteddisorders, genetic disorders, single gene disorders and cancers; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy, all for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single genedisorders and cancers; clinical medicalreagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing in the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers; pharmaceutical preparations, vaccines, prophylaxis medicines and other pharmaceutical preparations all for use in nucleic acid-based therapy, gene therapy and cell therapy in the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, fungal diseases, diseases caused by parasites, diseases affecting the immune system, inflammatory and auto-immune diseases, vascular disorders, bone diseases, inherited disorders, genetic disorders, single gene disorders and cancers |
| Goods and Services | Research, product development and consultancy in the field of biotechnology, biologics, pharmaceutics, medical science,chemistry and biochemistry |
| Goods and Services | Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders,muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 3, 2021 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 3, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 3, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, December 3, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | uniQure IP B.V. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BA NL |
| Party Name | uniQure IP B.V. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BA NL |
| Party Name | uniQure IP B.V. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Amsterdam 1105BA NL |
| Event Date | Event Description |
| Friday, December 3, 2021 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, May 26, 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, May 26, 2015 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 20, 2015 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Monday, December 1, 2014 | NOTICE OF ALLOWANCE CANCELLED |
| Thursday, January 15, 2015 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, December 1, 2014 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Tuesday, November 25, 2014 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 30, 2014 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 30, 2014 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 10, 2014 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, August 22, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Thursday, August 21, 2014 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, August 15, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 15, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, August 8, 2014 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Wednesday, August 6, 2014 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, August 6, 2014 | LETTER OF SUSPENSION E-MAILED |
| Wednesday, August 6, 2014 | SUSPENSION LETTER WRITTEN |
| Friday, July 25, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 25, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 25, 2014 | ASSIGNED TO LIE |
| Thursday, July 24, 2014 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, February 23, 2014 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Sunday, February 23, 2014 | NON-FINAL ACTION E-MAILED |
| Sunday, February 23, 2014 | NON-FINAL ACTION WRITTEN |
| Friday, February 14, 2014 | ASSIGNED TO EXAMINER |
| Tuesday, November 5, 2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, November 1, 2013 | NEW APPLICATION ENTERED IN TRAM |